About
OptimOva is a patented blood test method developed at Oslo University Hospital. The test personalises hormone dosing by fine-tuning the routine dosing standard and adjusting the prescribed dose to the patient's needs. The objective of this novel test is to optimise egg production, thus increasing the chances for having enough good quality embryos and ultimately improving chances for pregnancy and live birth delivery. In addition, excess good quality embryos are cryopreserved for future cycles, eliminating the need for further hormonal treatment.
Technologies
Wordpress.comGmailGoogle AppsNginxWordPress.orgMobile FriendlyQuantcast
Keywords
personalize medicineinfertilityin vitro fertilisationmedical diagnosticsheathcarestartupmedical sciencemedical equipment manufacturingbiotechnologyclinical trial developmentivf biomarker assay developmentegg cell number optimizationivf treatment optimizationhealthcare technologyfertility biomarkerfertility biomarker blood testclinical trial coordinationpatient-specific hormone managementtreatment safetyclinical decision supportbiomarker analysispersonalized medicineivf hormone fine-tuningblood biomarkerivf hormone managementhormone dosagebiomarker-based hormone adjustmentpatient-specific fertility treatmenthealthcarefertility biomarker assay
Company Information
- Employees3
- Founded2018
Location
Oslo, Oslo, Norway